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ABSTRACT
Rheumatoid arthritis (RA) is a chronic disease of the synovial joints. The
hand and wrist are the most commonly involved. The disease is characterized
by pain, inflammation, limited range of motion, and destruction of bone and
articular structures. In the later stages of RA, the person usually exhibits
deformity of the affected joints. This can result in the inability to use the hand in
a functional manner.
Rheumatoid arthritis affects approximately one percent of the population.
A person with RA usually has increased medical expenses. It is likely that the
person will experience a loss of productivity and income due to disability. The
mortality rate of individuals with RA is increased when compared to the general
public.
The purpose of this paper is to present an overview of RA including a
history of the disease, prevalence, cost and work disability, and mortality that
results from RA. In addition, the etiology and pathology of RA and common
deformities of the wrist and hand that result from the disease process will be
discussed. Physical therapy treatment of RA including patient education,
splinting, surgery, exercise and modalities is reviewed.
The physical therapist can be instrumental in educating the patient about
their disease, appropriate joint protection and energy conservation techniques,
and correct use of exercise and modalities to relieve pain and improve hand
function.
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CHAPTER I
INTRODUCTION
Rheumatoid arthritis is a chronic disease of the peripheral joints but
systemic symptoms may also be present. 1 Fleming et al 2 identified the most
common sites of initial involvement as the hand and wrist (36%), multiple joints
(29%), foot and ankle (19%), and other joints (16%). Gordon et al 3 found that
76% of individuals with a mean disease duration of 11 .5 years (range = 1 to 31
years) had extra-articular manifestations of the disease. The most common
extra-articular symptoms were subcutaneous nodules (53%) and pulmonary
fibrosis (20%). Pericarditis was the least common feature. Other manifestations
of the disease may include vasculitis, skin ulcerations, lymphadenopathy,
neuropathy, amyloidosis, and generalized osteoporosis. 3 ,4 The presence of
extra-articular manifestations was seen more frequently in patients with high
rheumatoid factor titers and those with severe articular destruction as seen on
x-ray.
The onset of RA may be sudden or insidious 2 and the rate at which
deformities develop may be fast or slow depending on the individual. s The
degree of severity exists on a continuum from mild and intermittent to severe and
continuous. 6 RA has a variable course so that a person can have symptoms at
one point in time and be symptom-free at later examination? The disease is
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characterized by pain, stiffness, limited range of motion, muscle atrophy,
destruction of cartilage and bone, and attenuation of supporting structures such
as ligaments and capsules which leads to subluxation and dislocation. 5
Although the disease can occur at any age, onset is most common
between 25 and 50 years of age. 1 Juvenile RA (JRA) begins before the child is
16 years 0Id. 1,8 It is considered to be a distinct disease, separate from adult RA.
There are three subtypes of JRA: systemic (Still's disease), pauciarticular
joints), and polyarticular

(~

(~4

5 joints), each presenting differently. Since JRA and

adult RA are considered to be different entities, further discussion will be directed
toward adult RA.
History
The first written record of RA is attributed to Augustin-Jacob LandreBeauvais, a French medical student. 9 In 1800, as the topic of his doctoral thesis,
Landre-Beauvais wrote about his observations of a previously unrecognized
disease that he called primary asthenic gout. The disease affected primarily the
small joints and was characterized by pain , swelling, loss of range of motion,
destruction of cartilage and bone, reduction of bone mass, and manifestation of
extra-articular symptoms. In addition, primary asthenic gout had residual
symptoms - swollen and deformed joints - that remained after the other
symptoms of the disease had resolved. Landre-Beauvais compared his findings
to classic gout, a recognized affliction of the era. He noted that primary asthenic
gout was seen more often in females and the poor, was less painful and of longer
duration than classic gout. In addition, classic gout usually occurred in a single
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joint whereas primary asthenic gout involved more than one joint. Primary
asthenic gout also lacked the deposits of sodium urate seen in the tissues of
individuals with classic gout. Fifty-nine years later, Sir Alfred Baring Garrod
introduced the term rheumatoid arthritis into the medical literature as the new
name for primary asthenic gout.
Although Landre-Beauvais is credited with recognizing the existence of a
separate disease,9 there is information suggesting that RA occurred prior to the
1800's. The writings of Thomas Sydenham from the late 1600's describe his
observations of a chronic disease with characteristics similar to those of RA.
Rothschild et al 10 examined 84 skeletons (3,000 to 5,000 years old) that were
excavated from an area in northwestern Alabama. Four females and two males
displayed evidence of symmetrical involvement and destruction of the synovial
joints. Rothschild and Woods 11 analyzed the skeletons of 129 Archaic Indians
(4,050 to 4,300 years old) that were found in Kentucky. The researchers found
evidence of decreased bone density and symmetrical, erosive arthritis of the
synovial joints in seven skeletons, five females and two males. Although this
evidence is not conclusive for the existence of RA prior to 1800, the
characteristics that the skeletons 10,11 displayed are common to individuals with
RA.
Dequeker12 and Appelboom et al 13 also found suggestions of the
existence of RA prior to the 19th century. Dequeker12 inspected Flemish portrait
paintings from the 15th through the 18th centuries and discovered that the
paintings revealed hand deformities similar to those seen in RA, including
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swan-neck and boutonniere deformities. After examining the 1ih century
paintings of Peter Paul Rubens, an European artist, Appelboom et al 13 concluded
that the paintings displayed the progression of deformity seen in RA.
There are several theories regarding the origin of RA. Charles Short9
theorized that ankylosing spondylitis was the initial form of rheumatic disease
and that RA evolved from this condition. Due to a lack of archeological evidence
suggesting the existence of RA in the Old World prior to 1800, Rothschild et al 10
proposed that RA originated in the New World and was transmitted to the Old
World - possibly by a vector, bacteria, or virus - with the advent of overseas
shipping and trade. Although there have been differing theories regarding the
origins of RA, to date, there have been no definitive conclusions. The possible
etiology of RA will be discussed further in chapter two.
Prevalence
The reported rates of definite RA range from 0.2% to 2.3% among
different countries and different racial backgrounds. 14-18 The female:male ratio
ranges from 2:1 to 3.75:1 14-17 ,19-23 and there is an increased prevalence with
increased age. 16 ,17,19-22,24-27
Results of the National Health Examination Survey (NHES) - 1960 to
196222 determined the prevalence of probable, definite, and classical RA to be
3.2% overall, 4.6% in women, and 1.7% in men. The percentage of people
affected decreased to 1.0% overall, 1.4% for women, and 0.5% for men when
cases of only definite and classical RA were considered. With regard to ethnicity,
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there was an equal prevalence among Caucasians and African-Americans with
higher rates among other races.
There is a widespread variance in the prevalence of RA according to age.
Moolenburgh et al

24

discovered that in Lesotho, S. Africa there were no cases of

definite RA in individuals under the age of 55. In contrast, the prevalence of
definite RA in female Yakima Indians from Washington state, ages 18 to 34, was
3.2%.25 Other studies of this young age group had rates of less than 1%.16,19,21,24
Comparability between studies is difficult because different criteria have
been used to classify cases of the disease. 14,19,20,24,25,26,28 There are four criteria
that frequently appear in the research - the American Rheumatism Association
(ARA) 1958 revised criteria,29 the ARA 1987 revised criteria,30 the Rome
criteria,31 and the New York criteria. 32 Comparisons of these criteria result in
dramatically different outcomes. 20 ,26 In addition, the various ages of subjects,
dissimilar methodologies, and use of different time frames makes comparison of
stUdies difficult or impossible. 14,15,1?,19,21,25
The fluctuating nature of RA, with remissions and exacerbations, makes
the prevalence of the disease difficult to measure. 6 As a part of the Tecumseh
Community Health Survey, Mikkelsen et al 21 conducted a study of all residents in
the community. Of the participants who were at least 16 years of age, the
prevalence of possible, probable, and definite RA combined was 7.6% overall,
10.0% for women, and 4.9% for men.
Four years later, 71.4% of the participants who were suspected of having
RA in the original Tecumseh study were reexamined .? Of the individuals
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diagnosed with definite arthritis in the original study, 21 % had no evidence of RA,
and 58% were diagnosed as having either a less severe classification of RA or
tested positive for rheumatoid factor without any other signs of the disease. The
individuals who were originally diagnosed with either possible or probable RA
displayed similar indications of remission. Similar results were reported by Wolfe
and HawleY,33 who determined that there was an 18.1 % remission rate among
persons having either definite or classical arthritis. Cathcart and O'Sullivan 34
found that 1/3 to 1/2 of those having either probable or definite RA during their
original studlO were symptom-free at follow-up four years later. As an
explanation, the researchers suggested the possibility that early RA may be a
benign, self-limiting process.
Cost and Work Disability
The financial burden of RA is considerable. Stone 35 estimated the lifetime
costs of RA including medical costs and productivity loss. The average lifetime
cost was ascertained to be $20,412 per person diagnosed with RA. Due to their
longer life expectancies, the dollar amount for individuals under 45 years of age
was $60,000 for men and $26,000 for women. Meenan et al 36 found that the cost
incurred by individuals with stage 111 37 RA, as defined in Table 1, averaged
$7,077 annually for those requiring hospitalization and $647 annually for others
who were not hospitalized 36 .
The cost of RA in terms of lost productivity and income is substantial.
Liang et al 38 found that RA limits a person's activity an average of 6.8 days each
month, including 2.5 days of lost employment and 1.3 days of bed rest. Yelin
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Table 1. - New York Rheumatism Association Classification of
Stages of Rheumatoid Arthritis*

Stage I

No bone or articular cartilage erosion evident on x-ray**
Evidence of osteoporosis may be evident on x-ray

Stage II

Evidence of osteoporosis on x-ray, with or without slight bone
erosion, slight destruction of cartilage may be present**
Lack of joint deformity, with or without limited joint mobility**
Adjacent muscle atrophy
Extra-articular soft tissue lesions may be present

Stage III

Evidence of cartilage and bone destruction on x-ray; evidence of
osteoporosis**
Joint deformity, i.e. subluxation or ulnar drift, without fibrous or bony
ankylosis**
Extensive muscle atrophy
Extra-articular soft tissue lesions may be present

Stage IV

Fibrous or bony ankylosis**
Presence of criteria in stage III

* adapted from Steinbrocker et al. 37
** these criteria are required for classification
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et al 39 discovered that 10% of the individuals who were working at the time of
diagnosis had stopped working within one year. By the fifth year, the percentage
had increased to 33% and 60% had ceased working after 15 years.
Yelin et al 40 determined that for persons with stage I or 11 37 RA, the
probability of becoming disabled was 0.444

°.

The probability increased to 0.72

for individuals with stage III or IV37 disease4o . The probability was not affected by
age, sex, race, or educational level. Single people had a 0.33 probability of work
loss compared to 0.67 for married individuals. The amount of autonomy
experienced at work also affected disability status. Individuals who were either
self-employed or able to adapt their work activities as needed were less likely to
become disabled. Reisine et al 41 found that the likelihood of a person becoming
disabled increased by 36 times if they experienced a lack of autonomy on the
job.
During a year-long study, Meenan et al 36 determined that 66% of
individuals with stage 111 37 RA made changes in their work situations and 86% of
these people became totally disabled 36 . The individual's occupation did not have
a significant effect on disability. In contrast, Reisine et al 41 found that individuals
were 6.8 times more likely to become disabled if their jobs were physically
demanding.
In summary, the loss of productivity and income due to disability is
considerable. 35 ,36,38-41 The severity of the disease, a person's marital status, and
the amount of autonomy in one's work environment appear to be important
determining factors in the development of disability due to RA. Disability not only
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affects the individual with RA and his or her family but it also has an effect on
society in terms of lost labor force and increased medical expenses.
Mortality
The mortality rate in individuals with

~

has been reported to be 1.5 times

higher than in the general population.23 ,42 Cardiovascular disease has been
reported as the most common cause of death 23 ,42-44 with rates similar to that of
the general population. 42 ,43 Other causes include infectious (pulmonary,
septicemia, peritonitis), respiratory, renal, gastrointestinal (bleeding,
perforations), and neoplastic diseases and urogenital sepsis.23 ,42-44
Complications of RA such as decubitus ulcers, spinal cord compression,
cachexia (general ill health and malnutrition), vasculitis, renal failure due to
amyloidosis, and rheumatoid heart disease have also been reported as causes of
death.43,44
Vandenbroucke et al 43 concluded that the proportion of individuals with RA
who died from infectious causes was 3.7 times higher than that of the general
population. Uddin et al 42 found that there was an increase of 7 to 10 times that of
the general population and hypothesized that the debilitating nature of the
disease may make the RA patient more susceptible to infection.
Studies also show that life expectancy of the individual with RA is
decreased. 23 ,42,43 Vandenbroucke et al 43 found that the median life expectancy
was three years less for women and seven years less for men when compared to
the general population. In contrast, Mitchell et al 23 estimated the median age at
the time of death to be ten years younger for women and four years younger for
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men. People that died of causes unrelated to RA had a longer life expectancy
(71.9 years) than those whose death was either directly related to or complicated
by RA (63.7 years).44
In summary, RA has a negative impact on the patient, his/her family, and
society in terms of increased medical expenses, work disability, and higher
mortality rate among individuals with RA. 23 ,35,36,38-44 The management of RA is
an important factor in minimizing the effect of the disease on all people involved.
The chapters that follow will discuss the etiology and pathology of RA, common
deformities of the wrist and hand that result from the disease process, and some
of the methods used to treat the disease.
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CHAPTER II
ETIOLOGY AND PATHOLOGY
Etiology
The etiology of RA is unknown.45 However, several substances including
various viruses have been investigated as possible causative factors.
Schumacher46 suggested viruses as a possible agent when he discovered viruslike particles in the synovial capillary walls of some RA patients. Further support
for the role of viruses as possible initiators of the disease process was offered by
Tosato et al. 47 These researchers observed the lymphocyte (non-phagocytic
white blood cells present in the lymph and blood - T and B cells) activity of
individuals with and without RA. All of the participants had been previously
infected with and successfully recovered from the Epstein-Barr virus (EBV). It
was concluded that the Band T cells of the people without RA responded with an
initial increase in the secretion of antibody followed by suppression of lymphocyte
activity after the antigen was destroyed. In patients with RA, this suppression did
not occur. The lymphocyte activity was suppressed by 94% in the group without
RA compared to 17% suppression in persons with RA. The results of this study
suggested that defective suppression of lymphocyte activity may result in
unregulated antibody production.
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Rheumatoid factor has also been mentioned as a possible causative
factor in RA. Rheumatoid factor (RF), an autoantibody that is produced by the
immune system,48 is present in 70% to 80% of individuals with RA.45 It is found
more frequently in older individuals 19,21 and is the most abundant antibody in the
immune complexes of RA patients. 49 Jasin48 analyzed cartilage samples from
people with RA and found that they contained 14 to 37 times more antibodies
than the cartilage of individuals without RA. In addition, RF-antibody complexes
were present in 81 % of the individuals with RA but were absent in the control
group. Vaughan 49 proposed that aggregates of RF may be capable of initiating
the immune response in RA patients.
It has also been suggested that RF may be an indicator for increased
susceptibility t07 and severity of RA.50 Alarcon et al 51 found that subcutaneous
nodules and vasculitis were present only in individuals with RF. In addition,
individuals who were RF(-) did not have the radiological changes that are
common with a diagnosis of RF(+) RA. 51 ,52 Rheumatoid factor appears with
equal frequency in men and women but women are diagnosed with RA two to
three times more often than men, 16,19,21 giving support to the hypothesis that RF
is important in the susceptibility to rather than being the cause of RA.
The presence of RF does not necessitate a diagnosis of RA. The NHES22
revealed that 2.6% of individuals were RF(+) but had no other signs or symptoms
of RA. Mikkelsen et al 21 obtained similar results. In addition, not all persons who
have symptoms of RA test positive for RF. 21 ,22 Calin and Marks 52 stated that the
symptoms described in the first five criteria used to classify cases of RA
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can

also be experienced by individuals with degenerative joint disease or ankylosing
spondylitis, conditions in which RF is usually absent. 52 It has also been shown
that a person may test RF(+) initially and test RF(-) at a later date?
Genetics have also been implicated in the cause and severity of RA but
there is conflicting data in this regard. Aho et al 53 determined that there was no
difference in the overall prevalence rate between monozygous and dizygous
twins. The researchers concluded that the participation of genetics in
determining the susceptibility to RA was minimal and that hereditary factors may
be more important in determining disease severity rather than susceptibility.
Wasmuth et al 54 discovered that the prevalence of RA was significantly
increased (p<O.001) in the first and second degree relatives of probands - the
persons who were initially diagnosed with RA - compared to the probands'
spouses. There was also a greater prevalence of RA among relatives when the
proband developed the disease early in life (between the ages of 15 and 34)
rather than later (between the ages of 55 and 74). From these results , the
researchers concluded that there may be a genetic component involved in the
development of RA. In addition, the spouses of probands had increased rates of
RA when compared to the spouses of relatives, leading the authors to postulate
that an environmental factor may also playa part in the acquisition of RA.
Certain human leukocyte antigens have also been seen more often in
individuals with RA compared to the general population. 51 ,55 Human leukocyte
antigens (HLAs) are molecules (receptors) on the surface of cells.56 The
receptors identify cells as being a part of the body rather than foreign
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substances. The HLA antigens, specifically the HLA-DR class, have been linked
to an increased risk of developing RA and to a more destructive course of the
disease. 51 ,55
Alarc6n et al 51 discovered that the distribution of HLA-DR4 was increased
(56.25% vs. 13.82%) in RF(+) patients compared to controls. However, when
comparing individuals having RF(-) RA to the control group, the distribution of
antigens was similar. The researchers found that RF(-) individuals who carried
the HLA-DR4 antigen [DR4(+)] were at higher risk for developing destructive
disease than RF(-) individuals who did not carry the antigen [DR4(-)]. Individuals
who were RF(-) and DR4(+) also had more severe grades of erosion on x-ray
films, increased use of remittive drug therapy such as gold, antimalarials, and
immunosuppressive medications, and greater amounts of destructive disease
than RF(-) individuals who were DR4(-). Calin et al 55 had similar results.
Nepom et al 57 examined individuals for the presence of HLA-Dw4 and
HLA-Dw14, alleles of the HLA-DR4 gene. One or both alleles were found in all
individuals with DR4(+), RF(+) RA. Sixty percent of the DR4(-) patients with
classic RA had a DR1 gene with a nucleotide sequence identical to the Dw14
allele. The researchers concluded that the presence of Dw4, Dw14, and the DR1
nucleotide sequence indicated a predisposition to RA in both DR4(+) and DR4(-)
patients.
In summary, there is support for the theory that there is a genetic
predisposition to RA51,57 and for the hypothesis that genes determine the severity
of RA. 51 ,55 Environmental factors may also play an important part. 54
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Pathology
According to Harris,45 there are five pathologic phases of RA. The first
stage is characterized by the presence of the causative factor (antigen) of RA.
There is development of capillaries and attraction of neutrophils (phagocytic
white blood cells) to the joint. The initial symptoms of pain and stiffness occur
when the macrophages release cytokine. Fatigue and malaise may be present
before the manifestation of joint symptoms.
Stages two and three are differentiated by the severity of the disease. 45
There is proliferation of T and B cells, production of antibodies by plasma cells
and activation of the complement system. Angiogenesis continues and plays a
role in the development of synovitis. Joint effusion, morning stiffness, and
destruction of cartilage begin during stage two but systemic symptoms are
usually not seen until the third stage. Medications are usually started during the
second stage in order to slow the progression of the disease.
During stage four, synovial tissue continues to proliferate and irreversible
damage occurs.45 The cartilage, ligaments and bone are all involved at this
stage. Stage five is a continuation of the process and medication will have little
effect on the disease during this stage.
The pathologic process of RA involves both the cell-mediated and antigenantibody immune responses. 45 Cell-mediated immunity involves the recognition
of antigen by macrophages. Once the antigen has been recognized, the
macrophage phagocytizes it. T lymphocytes bind to the macrophage-antigen
complexes, a process that stimulates the production of the cytokine interleukin-1
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(IL-1) by the macrophage. 56 Production of IL-1 leads to the differentiation of
specialized T cells - T-helper, T-suppressor, and T-cytotoxic cells. T-helper cells
produce the cytokine interleukin-2 (IL-2) which in turn stimulates several
processes including production of increasing numbers of T-helper cells,
activation of T-cytotoxic cells that lyse the macrophages containing the antigen,
and activation of B lymphocytes. The B cells differentiate into plasma cells that
participate in the antigen-antibody immune response known as complement.
In addition to IL-1 and IL-2, there are other cytokines including tumor
necrosis factor, gamma-interferon, and colony stimulating factor. 45 Cytokines
have several functions including the stimulation of: synovial cell proliferation,
release of prostaglandin and collagenase, and resorption of bone. They may
also be responsible for the fatigue and malaise that are often present before
symptoms of joint pain and stiffness appear. In addition, cytokines can induce
fever and pain and act as chemoattractants, bringing phagocytes to the injured
area. 56
Eastgate et al 58 found that the blood level of IL-1 was significantly higher
(p<O.001) in rheumatoid patients compared to control subjects. The researchers
also discovered that the increased level of IL-1 was positively correlated with the
number of affected joints, duration of morning stiffness, joint pain, and
erythrocyte sedimentation rate. The level of IL-1 was negatively correlated with
the hemoglobin level. The researchers postulated that IL-1 might contribute to
the development of anemia by inhibiting the production of erythropoiesis. The
complement system is made up of a series of proteins. 56 Once an antibody
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recognizes and binds with an antigen, the first protein attaches to the antigenantibody complex and activates the system. The proteins are activated
sequentially and each has a function. These functions may include capillary
vasodilatation, chemoattractant for phagocytes, or cytolysis - all of which result
in inflammation. Regulatory proteins are responsible for inactivating the system
when the antigen is destroyed.
The synovial tissue contains plasma cells that synthesize antibodies and
autoantibodies. 48 These substances are capable of forming antigen-antibody
immune complexes. Although the significance of these complexes is not known,
they may be responsible for the proliferation of diseased synovium and
destruction of cartilage and bone. Ruddy et al 59 demonstrated that the synovial
tissue produces proteins that are involved in the complement system. It can be
seen that, if the proteins necessary to activate the system are produced in the
synovial tissue and the antigen (which may be one's own tissues) is available to
bind with antibody, the system could easily become self-perpetuating.
During the disease process, the vasculature of the rheumatoid synovial
tissue is altered. Stevens et al 60 found that the density of capillaries in
rheumatoid synovium was one-third that of normal synovium. The vessels were
also located deeper within the tissue than usual. These conditions resulted in a
decreased availability of nutrients and oxygen to the tissue. The researchers
concluded that the hypoxic condition resulted in injury to the tissue and
postulated that the lack of oxygen was a factor in sustaining the inflammatory
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process. The antigen-antibody complexes that are formed are also capable of
causing the microvascular injury seen with RA.
The cells of rheumatoid synovium produce prostaglandins61 -63 and
collagenase. 62 Prostaglandins produce inflammation, vasodilitation, pain, and
edema,63 and stimulate bone resorption .61 ,63 Collagenase has been implicated in
the destruction of articular cartilage.62 Woolley et al 64 discovered that the
presence of collagenase in the joint was restricted to the cartilage-pannus
junction. Collagenase was found in the synovial tissue only 2% of the time. This
finding seems to correlate with Martel et al 65 who found that bone erosions are
most extensive at the joint margins where the bone is not covered by articular
cartilage. Once the articular cartilage has been destroyed, the bones are more
susceptible to compressive forces .
In summary, there are several theories regarding the etiology of RA
including viruses, RF, and genetics. 46-49 ,54 It is possible that environmental and
physiological factors contribute to an individual's susceptibility to the
disease.7,39,44,50-53 Regardless of the etiology of RA, it is known that the disease
process results in pathological changes within the joint and causes pain,
inflammation, and destruction of bone and articular cartilage. 45
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CHAPTER III
COMMON DEFORMITIES IN RHEUMATOID ARTHRITIS
In the wrist, the first sign of RA may be the appearance of tenosynovitis of
the extensor carpi ulnaris (ECU) tendon sheath followed by involvement of the
distal radioulnar joint. 66 The pathological process leads to destruction of the
triangular fibrocartilage (TFC) and distal subluxation of the ulna. Resnick67 found
that erosions of the distal radius and ulna were related to distal subluxation of the
ulna and perforation of the TFC, which allows communication between the
radioulnar and radiocarpal joints.
Martel et al 65 found that erosion of the ulnar styloid process occurred in

45% of persons with RA and separation of the distal radioulnar joint occurred in
41 % of the individuals. Erosion of the ulnar notch of the radius occurred in 21 %
of the people and was attributed to compressive forces resulting from destruction
of the TFC.
The TFC provides support for the ulnar carpus, stabilizes the distal
radioulnar joint to prevent dorsal subluxation,68 and transfers axial forces from
the radius to the ulna. 68 ,69 Destruction of the TFC allows the carpus to make
contact with the ulna. Direct articulation between the carpus and ulna prevents
full pronation and supination from taking place.
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The ligaments of the wrist provide stabilization while allowing controlled
motion between the carpal bones. 7o The destruction caused by RA - erosion of
bone and articular cartilage, and attenuation of ligaments and supporting
structures - causes narrowing of the joint spaces and results in restriction of all
motions at the wrist.1 1 Attenuation of the ligaments results in abnormal
movement of the carpals. 72 As an example, when the intercarpal ligaments
between the scaphoid and lunate are destroyed, these bones will separate. This
allows the capitate to settle between the two bones and results in the collapse of
the midcarpal joint. Kauer73 demonstrated that movement occurs at both the
radiocarpal and midcarpal joints and that each joint is equally important.
Another possible consequence of carpal dislocation is rupture of the flexor
pollicis longus and flexor digitorum profundus tendons to the index finger. 72 If the
intercarpal ligaments between the scaphoid and lunate are attenuated, the
scaphoid has a tendency to flex palmarly which allows the scaphoid tuberocity to
penetrate the palmar radiocarpal ligament, contact the muscles and weaken
them through attrition.71
Ulnar Drift
Ulnar drift of the phalanges is a deformity that is often seen in individuals
with RA and there are several theories regarding its development. Fearnle/4
proposed that ulnar drift of the phalanges occurs due to active use of the hand,
gravitational pull on the fingers, and muscle imbalances - ulnar dislocation of the
extensor tendons at the metacarpophalangeal (MP) joints and altered strength of
the intrinsic muscles.
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Vainio and Oka 75 developed a similar hypothesis as to the formation of
this deformity. When the fingers of the normal hand are extended, the phalanges
and the metacarpals form a straight line. When the fingers are flexed at the MP
joints, a small amount of ulnar drift occurs. It was hypothesized that as the
ligaments and capsule become attenuated, the radial collateral ligaments are
more vulnerable to stretching. The natural tendency of the fingers to assume an
ulnarly deviated position, use of the hand, and the integrity of the collateral
ligaments were found to be important in the development of deformity. Ulnar drift
was found twice as often in women (28.6%) than in men (14.6%). This finding
was attributed to the delicate bone structure seen in females, the different
activities performed by the genders, and the tendency of women to continue with
their household chores during periods of exacerbation. It was proposed that men
had more opportunities to rest during the acute stages of the disease. Patients
who were allowed to completely rest their joints during the acute inflammatory
phase did not develop any deformity of the MP joint.
Shapiro 76 noted that hands displaying ulnar drift also had radial deviation
of the carpus and that patients who developed ulnar drift during the course of the
study had a greater amount of radial deviation at the study's inception. He
concluded that radial deviation of the wrist initiated the process that resulted in
ulnar drift deformity. The long flexor tendons were then in a position of
advantage to exert an ulnar force on the MP joints and further exaggerate the
deformity.
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Although ulnar drift is commonly seen in all of the fingers, the fingers can
also be affected individually.74 The little finger acts as a block to the other fingers
and limits the amount of drift that the other fingers can undergo. If the capsule
and ligaments of the little finger are intact, only minor drift of the other fingers can
take place. However, if the ligaments are weakened, ulnar drift can develop
uninhibited and the ring, middle, and index finger are also free to drift.
Swan-Neck Deformity
Swan-neck deformity - hyperextension of the proximal interphalangeal
(PIP) joint and flexion of the distal interphalangeal (DIP) joint of the fingers - also
occurs in patients with

RA.77

With this deformity, patients experience a loss of

grasp but are still able to utilize the fingertip pinch. Swelling of the PIP joint
causes the lateral bands (the interosseous attachments) of the extensor hood to
displace to the dorsum of the hand. In this position, the interossei muscles are
unable to function independent of the extensor digitorum (ED) muscle. When the
ED contracts, the PIP joint becomes hyperextended. The flexor tendons attempt
to compensate for the loss of interosseous function and cause a secondary
flexion deformity at the DIP joint.
Boutonniere Deformity
Boutonniere deformity - extension of the MP joint, flexion of the PIP joint
and hyperextension of the DIP joint - is another common deformity that can
occur in the patient with RA. 77 The ED tendon (central slip of the extensor hood)
may rupture near its attachment to the base of the middle phalanx. If this
happens, as the ED contracts in an attempt to extend the PIP, only the MP joint
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extends. The PIP joint flexes and the DIP joint extends in order to maintain a
straight line of pull. The interossei are unable to prevent this motion because the
pathological condition of the extensor hood puts them at a mechanical
disadvantage.
Thumb Deformities
As many as 50% of people who have RA of the hand experience thumb
deformities.?? Synovitis of the MP joint is often the first sign of RA in the thumb.78
When the MP joint becomes inflamed, the extensor pollicis longus muscle
becomes ulnarly displaced and the extensor pollicis brevis muscle looses its
power to extend. The extensor muscles are placed at a mechanical
disadvantage and a flexion deformity of the MP joint results. If the deformity is
not corrected, the IP joint will become hyperextended.
Other deformities of the thumb are caused by synovitis occurring first at
the carpometacarpal (CMC) joint. 78 Synovitis in the CMC joint may result in
subluxation of the joint. The first metacarpal assumes an adducted position and
the adductor pollicis muscle becomes contracted. When this occurs, the MP joint
may become hyperextended with a compensatory flexion of the IP joint.
Conversely, the MP joint becomes flexed and the IP joint becomes
hyperextended. Regardless, deformities of the thumb can result in a loss of
grasp and finger pinch. This makes the hand virtually nonfunctional.
Spontaneous Fusion
The combination of articular cartilage destruction and limited movement
that occurs in RA can result in spontaneous arthrodesis (fusion) of an affected
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joint.1 1 The supporting structures of the PIP joint are more taut than those at the
MP joint, allowing less room at the PIP joint for joint effusion.74 This results in
greater limitation of movement at the PIP joint and makes it more vulnerable to
spontaneous fusion than the MP joint. The DIP joint is usually not affected.
In summary, the common deformities of the hand that occur in RA include
collapse of the wrist joint, ulnar drift at the MP joints, swan-neck and boutonniere
deformities, and various deformities of the thumb. In addition, the destruction of
articular cartilage combined with lack of joint movement can result in
spontaneous fusion of affected joints. A loss of function in the hand may occur
due to the development of any of these deformities.
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CHAPTER IV
TREATMENT
There is no cure for RA. Treatment of the disease involves control
of the symptoms. This chapter will focus on education of the patient, splints and
surgeries that can be used to minimize the deformities and improve function, and
exercises that may help alleviate the muscle weakness and other complications
that occur in RA.
Patient Education
Education is an important component of the overall treatment plan of the
patient with RA. Kay and Punchak79 conducted a study among 100 RA patients
recruited from a rheumatic disease center and found that patients were not
adequately informed about their disease. Fifty-four percent of the participants
said that they had received little or no information regarding the pathology,
symptoms, and prognosis that could be expected and 67% said that they would
like more information. Many stated that they used television, books, pamphlets,
magazines, radio, and newspapers to gain information about their disease. The
content of an educational program for people with RA might include information
about the disease and its symptoms,80.81 exercise techniques,80-82 joint
protection, relaxation,80.82 diet, use of modalities such as heat and massage,82
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social and functional difficulties, pain control ,80 control of anxiety, expression of
emotions, coping and stress management skills,81 and community resources .
Berg et al 80 found that patients reported improvement in their levels of
physical activity, mobility, activities of daily living (ADLs), and social activity six
months after attending patient education classes. There was a significant
improvement (p<0.001) in the patient's knowledge of RA, compliance with joint
protection and energy conservation techniques, and participation in an exercise
program . Davis et al 81 also demonstrated the benefits of patient education as
shown by increased knowledge and perceived self-efficacy, including ADLs, and
symptom and pain control (p<0.05) . Lorig et al 83 found that patients not only
increased their knowledge and compliance with exercise and relaxation
programs (p<0.01) but that pain was decreased by 20%, twice that of the control
group that had not received instructions. The number of visits also declined
although this result did not reach significance.
In contrast, Cohen et al 82 determined that there was little difference in the
self-management behaviors of individuals after attending an educational course.
These researchers found that exercise was the only behavior that significantly
increased after attending six weekly education classes. Neither the degree of
disability nor the patient's subjective pain levels was altered.
There is also contradicting evidence regarding the effect that education
has on the patient's psychological status. Lorig et a1 83 ,84 reported that not only
did patient's increase their compliance with exercise and relaxation techniques
(p<0.01), but they also experienced a decrease in their symptoms of depression
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(p<O.05). This study contrasts with the results obtained by Goeppinger et al

85

who determined that in spite of significant improvement in the patient's
knowledge of RA, performance of self-care behaviors, and level of perceived
helplessness, the level of depression experienced by these patients was
unchanged.
The instruction style may not be as important as the fact that the
information is made available to the individual. Lorish et al 86 conducted an
experiment with patients who were in a hospital setting . Three teaching methods
were used:
1. individualized (I) instruction containing content that was adjusted to the
patient's knowledge of RA, physical condition , and emotional status
2. a routine (R) program that utilized formatted self-instruction and contained
information about the disease and home care issues
3. no planned (NP) instruction which included instructions on how to
correctly perform a home program without any additional information
except responses to questions asked by the patient.
Although all of the programs demonstrated significance in the ability to
convey knowledge, the I program was rated significantly higher when compared
to the other two programs. All patients in the I program demonstrated a gain in
their knowledge base compared to 65% of the patients in the R group and 78% in
the NP program. Other studies 82 ,85 have also shown significant gains in
knowledge utilizing various teaching methods including small groups,
self-instructed programs, or the use of professionals versus lay instructors.
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After a patient has been diagnosed as having RA, he or she may be
referred to physical therapy. Because the therapist often spends a considerable
amount of time with the patient, the patient may rely on his or her therapist as a
source of information. The physical therapist can be an important resource and
direct the patient to other professionals as needed.
Splinting
There are various types of splints available that can be used in the
treatment of RA hand deformities. 8?-104 Splints are used for a variety of reasons
including 1) pain relief 2) decreasing inflammation 3) correcting deformities
4) creating functional deformities 5) post-surgical rehabilitation 8? and 6)
increasing function. 88 Features to consider when choosing a splint include
durability, simplicity of construction, comfort, lightweight, cosmesis, and ease of
donning and doffing.89
Compliance should be considered when initiating a splinting program.
Some of the reasons cited for non-compliance include a decrease in pain levels
so the patient felt that splinting was no longer necessary, increased joint
stiffness, inconvenience, and discomfort.90 Callinan and Mathiowetz 91 compared
hard resting hand splints (thermoplastic with straps) with soft resting splints
(fabric outer cover with a thermoplastic insert) and found that compliance rates
were 67% and 82%, respectively. Fifty-seven percent of the participants
preferred the soft splint.
Splinting should minimize restriction by preventing faulty movements while
allowing movements that can be performed correctly.89 VanBrocklin 88 described
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a cock-up splint that can be made to support the wrist only or a platform can be
added that limits flexion of the MP joints or fingers. The points of pressure and
the straps are placed such that they help to provide optimal alignment of the
structures and reduce stress on the joints. Smith et al 92 suggested the use of a
splint that supports the wrist and minimizes flexion at the MP joint. Bennett89
described several splints that can be used either to prevent or correct deformities
and restore hand function. He stated that the use of splints must be part of a
comprehensive program that also includes maintenance of muscle strength and
limitation of activity.
The ability to obtain correction of deformity is dependent on the integrity of
the tissues surrounding the joint. 93 If the tissue has lost its flexibility, correction
may not be possible. Extensive bone erosion may also result in faulty movement
at the joint. 89 Early intervention is important. Convery et al 87 found that dynamic
splints are an important component of the post-operative rehabilitation process
but they are not beneficial in the prevention of deformity.
Nordenskiold 94 compared two prefabricated elastic wrist orthoses and
found that RA patients experienced as much as 52% less pain if the orthoses
were worn during the performance of activities of daily living. Grip force was
improved by up to 29% but was not restored to normal as defined by the control
group. In contrast, Stern 95 found no significant difference in grip strength when a
wrist splint was used. A disadvantage of this type of brace is that it can interfere
with the performance of some activities 94 by reducing finger dexterity and hand
function .94 ,96 Stern 95 discovered that finger dexterity is affected by some types of
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commercial wrist orthoses but is unaffected by others. Fingertip pinch can also
be significantly improved by splinting. 93
Surgery
Surgery is indicated for the treatment of RA in order to reduce pain,
correct deformity, improve function, and for cosmetic reasons. 104 The objectives
of surgery include removal of diseased synovium, prevention or repair of ruptured
or adhered tendons, and providing stability to the involved jOints. 55 Twenty-five
percent of the surgeries performed for arthritis are performed on the hand. 105
This chapter will discuss the surgeries that are most commonly performed as
treatment for RA.
Synovectomy and Tenosynovectomy - Synovectomy is a procedure that involves
excision of the synovial tissue from a joint. 106 Tenosynovectomy is the removal
of the sheath surrounding a tendon. The procedures are often performed at the
same time 105 during the early stages of RA 104 ,107 when there is a minimal amount
of deformity and conservative measures - medications and rest - have been
unsuccessful in treating the patient's symptoms of pain and
inflammation.104,105,1o7 In addition to reduction of pain, synovectomy slows the
destruction of cartilage and tendons and helps to improve function. 1oB Straub
and Ranawat66 found that the success rate of synovectomy in controlling
synovitis was 99.4% after one year and 92.5% after five years.
Synovectomy and tenosynovectomy are performed by cutting through the
extensor retinaculum. 104 The synovium is then removed from the tendons and
joint spaces. Because of its location, the synovium cannot be completely
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removed. 104,105 Norris 104 stated that only 60% of the synovium can be removed
in the wrist and hands. Following surgery, Straub 107 recommended postoperative splinting for 10 days to allow the soft tissues to heal.
Tenosynovectomy of the flexor tendons may be performed if median nerve
compression is causing symptoms of carpal tunnel syndrome. 104 During this
procedure, the bones of the carpal tunnel are inspected. 107 This helps to ensure
that the bones are smooth in order to reduce the likelihood of tendon rupture.
Tenosynovectomy of the finger tendons is rarely performed because the pain and
stiffness that result from the procedure have limited its popularity.108 If a flexor
tenosynovectomy is performed, Straub and Ranawat66 recommended that
compressive dressings be applied for 24 to 48 hours with active range of motion
being initiated 48 hours after surgery.
Darrach Procedure - This procedure involves excision of the distal ulna and is
often performed simultaneously with synovectomy and
tenosynovectomy.105,107,108 If too much of the ulna is removed, the distal
radioulnar joint will become unstable and fail to provide the support needed by
the ulnar carpus.
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After the joint spaces are cleared of synovium, the extensor

tendon is placed under the extensor tendons, providing a smooth surface for the
tendons to glide on, and any ruptured tendons are repaired. A loop can be
made, using a portion of the extensor retinaculum, to correctly position the ECU
tendon and hold it in place. A cast is worn for six weeks, after which active range
of motion is started. A 60° arc of motion can be expected after performance of
this procedure.
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Arthroplasty - The goal of arthroplasty is to relieve pain, correct deformity, and
gain stability and additional movement in the joint. 105 Synovectomy of the joint is
performed prior to prosthetic placement. 108 The intramedullary canals are then
reamed and the prosthesis is fit to the joint.
In the wrist, there are two types of prosthesis that are commonly used: the
Meuli three component metal-polythene-mental prosthesis and the Swanson
flexible silastic implant. 104 The metal components are cemented in place. 108 The
silastic prosthesis is held in place by the capsule and ligaments surrounding the
joint. 105 Both component types can loosen and dislocate. 104 Because it is not as
strong, the silastic implant is recommended for those patient's who will be
performing only light-duty activities. 105 After arthroplasty of the wrist, Ranawat
and Rosenberg 108 recommended that the joint be immobilized for four weeks.
Active exercise can then be initiated with an estimated return of a 60° flexionextension arc of motion.
Ranawat and Rosenberg 108 suggested that arthroplasty of the MP joint be
followed by five days of immobilization, after which the use of a dynamic splint
and active exercise can be performed. Exercise and the use of a dynamic splint
was also recommended by Altissimi and Ciaffoloni. 105 It is common to gain 50°
to 70° of flexion in the MP joint after surgery. The protocol for arthroplasty of the
proximal interphalangeal joint is similar. 108 Arthroplasty of the CMC joint of the
thumb can also be performed and is usually accompanied by fusion of the first
MP and IP joints. A thumb spica cast is used to immobilize the joint for four
weeks before exercise is begun.
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Arthrodesis - Arthrodesis (fusion) is performed when deformities, instabilities and
pain are severe.105 This procedure is also recommended as an alternative to
wrist arthroplasty for people who will be involved in heavy-duty activities.
Arthrodesis offers relief of pain and improvement of function. 108 The
disadvantage of the procedure is that the joint range of motion is lost. For this
reason , arthrodesis is not performed on the MP joints of the fingers or the CMC
joint of the thumb.
In the wrist, tenosynovectomy,66 synovectomy,108 and ulnar head removal
are performed as part of the procedure. The articular cartilage is then removed
from the joint and the bones are smoothed. Bone grafts are placed in the joint
spaces to further reinforce the joint. 66 ,1 08 Pins are used to secure the bones in
proper position . The wrist is immobilized for six to eight weeks. Removal of the
pins takes place after the bones are solidly united. 66 The PIP and DIP joints of
the fingers and the MP and IP joints of the thumb can also be fused using a
similar procedure. 108
Tendon Surgery - Tendon surgery is performed to repair ruptured tendons and
minimize deformity.104 The tendon repair can be done end-to-end (suturing the
tendon back together) or end-to-side (suturing the ruptured tendon to an adjacent
tendon) . The extensor pollicis longus and the extensor digitorum tendons of the
ring and little fingers are ruptured most often .66 ,104 The extensor indices can be
transferred to the thumb to replace the extensor pollicis longus 105 but it is only
strong enough to extend one digit. The flexor digitorum superficialis can be
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transferred to the extensor surface to extend more than one finger if
necessary.104
If there is minimal bone erosion of the MP joints, ulnar drift can be
minimized by performing a synovectomy of the joints and relocating the extensor
tendons so that they have the correct line of pull. 104 Crossed intrinsic transfer, a
procedure in which the intrinsic tendons on the ulnar sides of the fingers are
divided then reattached on the radial side of the adjacent finger, is also used to
strengthen the pull of the muscles on the fingers in the radial direction. After
insertion of MP prostheses to each of the fingers, the radial collateral ligament of
the index finger is tightened and the crossed intrinsic transfer is performed to
help correct the ulnar drift deformity. The joint is immobilized for two weeks in
slight flexion and then a dynamic splint is utilized for six weeks to help maintain
extension during the day. A resting splint is used at night. A radial abduction
splint can be used as a prophylactic to resist ulnar deviation that might occur in
the future.
Exercise
Amick
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conducted electromyographic (EMG) studies on RA patients and

normal controls. He found that the groups had similar readings for nerve
conduction times, threshold intensity for stimulation, and duration and amplitude
of motor unit action potentials. From these results, he proposed that the muscle
atrophy commonly seen in patients with RA was due to disuse rather than lower
motor neuron disease. Wozny and Long 110 obtained similar EMG results.
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Bens et al 111 described a device called the "Hand Gym" that can help the
patient perform hand exercises correctly. This apparatus assists the individual in
maintaining the proper position needed to stretch and strengthen the intrinsic
muscles of the hand. Schaufler et al 112 found that over a four-month period RA
patients were able to increase PIP joint range of motion an average of 7.6 0
(p<0.001) by using the device. Grip strength, palmar pinch, and lateral pinch
were also increased significantly (p<0.001 to <0.05). Brighton et al 113 discovered
a significant increase in grip strength (p<0.0001) and pincher strength (p<0.0005)
after participation in a two-year exercise program. Hoenig et al 114 also suggested
that hand exercises may be beneficial.
Smith et al 92 suggested that the strong forces of the flexor tendons need to
minimized and that this can be done by changing the way that the hand is used.
These researchers proposed that the hand be used as a hook, such as when
carrying a pail. This keeps the MP joints extended. Pinch and grasp should be
avoided. Instead, the hand can be used in a scooping fashion to pick up objects
or the objects can be grasped between the palms of both hands. The
researchers suggested that the patient avoid squeezing activities as part of an
exercise program since this would tend to further strengthen the flexor muscles.
The following exercises might be included in a stretching and
strengthening program for the hands:
1. placing the hand flat on a table and lifting each finger off the table
individually113
2. gathering and ungathering a towel 113
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3. pinching a sheet of paper between the thumb and each individual
finger and attempting to pull the paper out113
4. placing the palm flat on a table with the MP joints at the edge of the
table, then flexing and extending the fingers at the MP joints, repeating
the exercise at the PIP joints 113
5. resisted finger abduction and adduction 111
6. flexing the PIP and DIP joints while maintaining the MP joints in
extension 111
Wehbe 115 described exercises to help prevent the flexor and extensor
tendons from becoming adhered and stretch the intrinsic muscles. They include
making a fist in three different ways:
1. with the MP, PIP, and DIP joints flexed
2. with the MP joint extended and the PIP and DIP joints flexed
3. with the MP and PIP joints flexed and the DIP joints extended
Dellhag et al 116 demonstrated that participation in an exercise program
can significantly improve range of motion and grip strength in the hand. These
researchers also concluded that a paraffin wax bath was effective in reducing
pain and stiffness but did not result in increased hand function if used without
exercise. Hawkes et al 117 tested three modalities - ultrasound, paraffin, and a
faradic hand bath - followed by exercise. Each of the treatments showed
significant reductions in pain and significant increases in grip strength and range
of motion. Because each of these treatments was associated with a significant
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increase in strength and range of motion, it would not seem inappropriate for
patients to use modalities in addition to exercise for the relief of pain.
In summary, it appears that patient education can enhance the patient's
knowledge about RA and have a positive effect on the level of participation in
physical and social activities. 8o Education may increase the individual's ability to
control the symptoms of the disease and enhance perceived self-efficacy.81 The
patient should also be educated in techniques of joint protection and energy
conservation. Splinting is used for pain relief, correction of deformities, after
surgery, to reduce stress on the joints, and to improve hand function .87 ,88,104
Surgery is performed in the early stages of RA to remove the diseased
synovium. 104,107 In the later stages of the disease, arthroplasty and arthrodesis
are performed to correct deformity and relieve pain. 105 Exercise also plays an
important part in maintaining and improving hand function. 112,116
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CHAPTER V
CONCLUSION
Rheumatoid arthritis is a chronic rheumatic disease that affects primarily
the small synovial joints of the body. The joints of the hand and wrist are most
commonly involved but any synovial joint can be affected.

2

The disease can

develop at any age. Juvenile RA is defined as a disease that has its onset
before 16 years of age. 1,8 The onset of adult RA is usually between 25 and 50
years of age and affects females more frequently than males. 1 The prevalence
of the disease increases with increased age.
The etiology of RA is unknown.45 Several theories have been postulated
to explain the origins of and susceptibility to the disease including viruses, RF,
genetics, and environmental factors. 7,39,44,46-54 The signs and symptoms of RA
include pain, inflammation, joint effusion, limited range of motion, destruction of
bone and articular cartilage, and attenuation of ligaments and joint capsules. 5
The disease can also present with systemic complications. 3 ,4 The symptoms can
be mild or severe, intermittent or continuous. 6 Most individuals experience
exacerbations and remissions of symptoms?
The person with rheumatoid arthritis in its later stages usually experiences
deformity in the affected joints. 74-78 In the hand, these deformities often result in
a loss of function which can interfere with the person's lifestyle. 38 These
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individuals have increased medical expenses, lost productivity at work, and
higher rates of work disability than the general population. 35-41 There is also a
higher mortality rate associated with RA.23.4 2
Physical therapy treatment of RA involves a variety of treatments including
patient education, splinting, post-surgical rehabilitation, and exercise. Patient
education can help the individual with RA understand the basic pathology of RA
and management of the disease. 79-B2 Splinting can be used to aid in maintaining
correct joint alignment and reducing stress on the jOints. B7 ,BB Surgery can also
used to help minimize deformities. 66 ,104 After surgery, there is often a period of
immobilization. 66 ,104,105,107,10B Physical therapy treatment mayor may not be a
part of the patient's post-surgical rehabilitation program. Exercise can be used to
help maintain range of motion and strength .112 ,116 Modalities can reduce pain
and stiffness and have been shown to be beneficial when used in combination
with an exercise program.116 ,117 The exercise program should be tailored to
meet the specific needs of the individual and help prevent complications of the
disease.
The physical therapist (PT) often spends a considerable amount of time
with the patient. It is this author's opinion that the relationship that develops
between the physical therapist (PT) and the patient can be instrumental in
helping the patient cope with his/her disease. If the patient feels comfortable
confiding in the PT, information may be gained about the patient's lifestyle that
can be used to help plan an appropriate treatment plan. If a treatment plan is not
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conducive to the patient's lifestyle, it is likely that their will be a low level of
compliance.
A treatment plan should include patient education about the pathology of
the disease, exercise, joint protection, energy conservation, use of modalities,
pain control, and coping techniques. 8o-82 Vanio and Oka 75 found that continuing
to use the hand during an exacerbation of RA symptoms resulted in increased
deformity. Splints can be used to help rest the joints in proper alignment in order
to minimize deformity. The PT can instruct the patient in the proper performance
of exercise and energy conservation in order to protect the joints from injury. The
PT can help the patient develop alternative methods for completing activities.
This may enable the person to remain productive and reduce his/her
independence on others.
Further research is needed to determine the etiology of RA and increase
understanding of the disease process. Until a cure can be found, the PT can
help the patient cope with the chronic manifestations of RA and perhaps provide
methods of disease management that will enhance the patient's independence.
A better understanding of RA will allow the development of more effective
treatment methods.
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